World J Urol (2012) 30:279–285 40. Medici D, Hay ED, Olsen BR (2008) Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor- beta3. Mol Biol Cell 19(11):4875–4887 41. Kim K, Lu Z, Hay ED (2002) Direct evidence for a role of beta- catenin/LEF-1 signaling pathway in induction of EMT. Cell Biol Int 26(5):463–476 42. Wallerand H, Robert G, Pasticier G, Ravaud A, Ballanger P, Reiter RE, Ferriere JM (2010) The epithelial-mesenchymal transition-inducing factor TWIST is an attractive target in advanced and/or metastatic bladder and prostate cancers. Urol Oncol 28(5):473–479 43. Jaggi M, Johansson SL, Baker JJ, Smith LM, Galich A, Balaji KC (2005) Aberrant expression of E-cadherin and beta-catenin in human prostate cancer. Urol Oncol 23(6):402–406 285 44. Hodgson MC, Shao LJ, Frolov A, Li R, Peterson LE, Ayala G, Ittmann MM, Weigel NL et al (2011) Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer. Cancer Res 71(2):572–582 45. Memarzadeh S, Cai H, Janzen DM, Xin L, Lukacs R, Riedinger M, Zong Y, Degendt K et al (2011) Role of autonomous androgen receptor signaling in prostate cancer initiation is dichotomous and depends on the oncogenic signal. Proc Natl Acad Sci USA 108(19):7962–7967 46. Xin L, Teitell MA, Lawson DA, Kwon A, Mellinghoff IK, Witte ON (2006) Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor. Proc Natl Acad Sci USA 103(20):7789–7794 123